Literature DB >> 16254031

Nongenomic action of progesterone inhibits oxytocin-induced phosphoinositide hydrolysis and prostaglandin F2alpha secretion in the ovine endometrium.

Cecily V Bishop1, Fredrick Stormshak.   

Abstract

Experiments were conducted to characterize the nongenomic effects of progesterone (P4) on binding of oxytocin (OT) to its receptor and signal transduction in the ovine endometrium. The dose-response relationship of P4 to OT binding was examined. Membranes from endometrial tissue of ovariectomized hormone-treated ewes were preincubated in the presence of P4 for 1 h followed by OT receptor analysis. P4 interfered with the binding of OT in a dose-dependent manner. Endometrium was then recovered from cyclic ewes and divided into explants. Treatment consisted of two dosages of P4 and two dosages of OT. Explants were analyzed for total inositol monophosphate, bisphosphate (IP(2)), and trisphosphate (IP(3)) content. Preincubation with P4 for 10 min significantly interfered with OT stimulation of IP(2) and IP(3) synthesis. Oxytocin increased monophosphate production, but there was no detectable effect of P4. In the next experiment, endometrial explants were cultured in the absence or the presence of arachidonic acid. Explants were then exposed for 1 h to medium containing vehicle or P4. After incubation, explants were challenged with OT and the media were collected and analyzed for 13,14 dihydro-15-keto prostaglandin F(2alpha) by RIA. Treatment of explants with AA increased PGF(2alpha) content compared with that of controls. Brief exposure to P4 significantly decreased OT-induced PGF(2alpha) secretion from explants previously exposed to medium or AA. Collectively, these data are interpreted to indicate that the observed reduction in OT-induced IP(2) and IP(3) production and OT-induced PGF(2alpha) secretion was due to P4 inhibition of OT binding to its receptor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254031     DOI: 10.1210/en.2005-0869

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Calmodulin potentiates G beta gamma activation of phospholipase C-beta3.

Authors:  Jennifer S McCullar; Dean A Malencik; Walter K Vogel; Kristi M Crofoot; Sonia R Anderson; Theresa M Filtz
Journal:  Biochem Pharmacol       Date:  2006-10-13       Impact factor: 5.858

2.  Progesterone suppresses an oxytocin-stimulated signal pathway in COS-7 cells transfected with the oxytocin receptor.

Authors:  Cecily V Bishop; Theresa Filtz; Yong Zhang; Ov Slayden; Fredrick Stormshak
Journal:  Steroids       Date:  2008-07-16       Impact factor: 2.668

3.  PI(3,4,5)P3 potentiates phospholipase C-beta activity.

Authors:  Yong Zhang; Sun Hyung Kwon; Walter K Vogel; Theresa M Filtz
Journal:  J Recept Signal Transduct Res       Date:  2009       Impact factor: 2.092

4.  Progesterone inhibits oxytocin- and prostaglandin F2alpha-stimulated increases in intracellular calcium concentrations in small and large ovine luteal cells.

Authors:  Tracy L Davis; Rebecca C Bott; Teresa L Slough; Jason E Bruemmer; Gordon D Niswender
Journal:  Biol Reprod       Date:  2009-10-07       Impact factor: 4.285

5.  PGRMC1 and PGRMC2 in uterine physiology and disease.

Authors:  James K Pru; Nicole C Clark
Journal:  Front Neurosci       Date:  2013-09-19       Impact factor: 4.677

6.  Progesterone inhibition of oxytocin signaling in endometrium.

Authors:  Cecily V Bishop
Journal:  Front Neurosci       Date:  2013-08-07       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.